VRCA
NASDAQ · Pharmaceuticals
Verrica Pharmaceuticals Inc
$5.08
-0.28 (-5.22%)
Analyst Consensus
Strong Buy
12
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+88.8% upside
Low Target
$7.88
Average Target
$9.59
High Target
$13.36
Current Price
$5.08
Current
$5.08
$5.08
Target
$9.59
$9.59
$7.88
$9.59 avg
$13.36
Scenario Analysis
Bear Case
$7.88
55.1%
Low target
Base Case
$9.59
+88.8%
Avg target
Bull Case
$13.36
+163.0%
High target
Risk/Reward
3.0x
Favorable
Price in Context
52-Week High
$9.82
-48.3% from high
52-Week Low
$3.28
+54.9% from low
Target vs 52W High
$9.59
-2.4% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $-0.38
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals